Solina approaches every project with the rigor and dedication needed to deliver the highest quality of results. Because we work on issues of high importance with far-reaching implications, we make certain that our insights are based on rigorous research and analysis of evidence.

Routine Immunization Buddy System (RIBS)

This is an intervention research project funded by the Gates Foundations’ Grand Challenges Exploration (GCE) grant. RIBS is a human-centered solution aimed at removing barriers that hinder the Northern Nigerian woman from demanding and accessing immunization services, by empowering her with practical knowledge on vaccination, providing access to loans to boost her financial capability and a network of peers for psychosocial support. This research will help derive insights that will contribute to the knowledge base influencing demand generation strategies and inform potential scale-up to other parts of the state, the country and other PHC program areas.

Digital Payments Health Initiative and Research (DPHI-R) project

SCIDaR is providing program management and research support for the Digital Payments Health Initiative and Research project, which is funded by the Bill & Melinda Gates Foundation (BMGF). This 3-year project is being implemented by two African public health institutions, Makerere University School of Public Health (MaKSPH) for anglophone countries and University Cheikh Anta Diop (UCAD) for francophone countries, to catalyse the generation of evidence on the impact of digitised payments for health workers on the quality of immunisation and other health campaigns.

HPV vaccination policy and advocacy research program

To promote the equitable access and utilisation of the HPV vaccine in Nigeria, the HPV vaccination policy-research program aims to generate evidence to support HPV vaccine introduction and uptake in Nigeria and facilitate the dissemination, adoption, and implementation of research findings, with a timeline of 21 months from February 2023 to November 2024. 

Cervical cancer is a significant public health concern, especially in Nigeria, where it is a leading cause of cancer-related deaths among women. Human papillomavirus (HPV) is the primary cause of cervical cancer, and vaccination is a safe and effective strategy for preventing it.